These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2068463)

  • 1. Aztreonam in the treatment of gram-negative bacterial meningitis.
    Lentnek AL; Williams RR
    Rev Infect Dis; 1991; 13 Suppl 7():S586-90. PubMed ID: 2068463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aztreonam in the treatment of gram-negative meningitis in children.
    Isani Z; Rehman N; Adil N; el Messidi M
    Chemioterapia; 1987 Jun; 6(2 Suppl):428-30. PubMed ID: 3334590
    [No Abstract]   [Full Text] [Related]  

  • 3. Aztreonam in the treatment of gram-negative meningitis and other gram-negative infections.
    Feris J; Moledina N; Rodriguez WJ; Khan WN; Puig J; Wiedermann BL; Ahmad S
    Chemotherapy; 1989; 35 Suppl 1():31-8. PubMed ID: 2731448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aztreonam in the treatment of bacterial meningitis.
    Ayroza-Galvão PA; Milstein-Kuschnaroff TM; Mimica IM; Maassen S; Barbosa Júnior SP; Cavalcante NJ; Lorenco R; Mimica LM; Martino MD
    Chemotherapy; 1989; 35 Suppl 1():39-44. PubMed ID: 2731449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aztreonam in the treatment of aerobic, gram-negative bacillary infections in pediatric patients.
    Trujillo H; Harry N; Arango A; Benítez G; Restrepo F; Mejía GI; Castrillón AL
    Chemotherapy; 1989; 35 Suppl 1():25-30. PubMed ID: 2731447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of aztreonam in the treatment of neonatal sepsis.
    Sklavunu-Tsurutsoglu S; Gatzola-Karaveli M; Hatziioannidis K; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S591-3. PubMed ID: 2068464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aztreonam therapy for serious gram-negative infections in children.
    Stutman HR; Chartrand SA; Tolentino T; Friedhoff L; Marks MI
    Am J Dis Child; 1986 Nov; 140(11):1147-51. PubMed ID: 3766490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of aztreonam against pediatric purulent meningitis].
    Fujii R; Meguro H; Nishimura T; Kobayashi Y; Haruta T; Toyonaga Y; Okada T; Furukawa S; Kitamura I; Ogura H
    Jpn J Antibiot; 1988 Apr; 41(4):390-8. PubMed ID: 3136257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aztreonam for treating meningitis caused by gram-negative rods.
    Kilpatrick M; Girgis N; Farid Z; Bishay E
    Scand J Infect Dis; 1991; 23(1):125-6. PubMed ID: 2028226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parenteral aztreonam in the treatment of Haemophilus influenzae type b meningitis in Egyptian children.
    Girgis NI; Abu el Ella AH; Farid Z; Woody JN; Haberberger RL; el Messidy M; Dessouky A
    Scand J Infect Dis; 1988; 20(1):111-2. PubMed ID: 3259009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What is safe in the therapy of purulent meningitis?].
    Rosin H
    Internist (Berl); 1981 Dec; 22(12):739-43. PubMed ID: 7033164
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of aztreonam in therapy for experimental bacterial meningitis and cerebritis.
    Scheld WM; Brodeur JP; Foresman PA; Gratz JC; Rodeheaver GT
    Rev Infect Dis; 1985; 7 Suppl 4():S635-47. PubMed ID: 3909319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bacterial meningitis with ceftazidime.
    Hatch D; Overturf GD; Kovacs A; Forthal D; Leong C
    Pediatr Infect Dis; 1986; 5(4):416-20. PubMed ID: 3523458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moxalactam for the treatment of bacterial meningitis in children.
    Freedman JM; Hoffman SH; Scheld WM; Lynch MA; da Silva HR; Rocha H; Sande MA
    J Infect Dis; 1983 Nov; 148(5):886-91. PubMed ID: 6415181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of aztreonam in the treatment of patients with renal failure.
    Sion ML; Pyrpasopoulos M; Nicolaidis P; Papagianni C; Tsurutsoglu G
    Rev Infect Dis; 1991; 13 Suppl 7():S652-4. PubMed ID: 2068477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moxalactam therapy for gram-negative bacillary meningitis.
    Rahal JJ
    Rev Infect Dis; 1982; 4 Suppl():S606-9. PubMed ID: 6218572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall clinical experience with aztreonam in the treatment of intraabdominal infections.
    Henry SA
    Rev Infect Dis; 1985; 7 Suppl 4():S729-33. PubMed ID: 3909331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.